Magnus Essand

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

News from the T cell trogocytosis front.

News from the T cell trogocytosis front.

Journal: Trends in immunology

Published: June 12, 2025

Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domains.

Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domains.

Journal: Science immunology

Published: January 31, 2025

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas.

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas.

Journal: Cancer immunology, immunotherapy : CII

Published: August 26, 2024

Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response.

Targeting ZC3H11A elicits immunogenic cancer cell death through augmentation of antigen presentation and interferon response.

Journal: Molecular therapy. Nucleic acids

Published: March 26, 2024

VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier.

VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier.

Journal: Nature communications

Published: October 24, 2023

Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer.

Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer.

Journal: Frontiers in immunology

Published: August 09, 2023

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: May 19, 2023

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 20, 2023

ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression.

ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression.

Journal: Frontiers in immunology

Published: July 25, 2022

Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response.

Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response.

Journal: Oncoimmunology

Published: July 21, 2022

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: June 17, 2022

CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.

CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.

Journal: Nature

Published: June 16, 2022

Showing 1-12 of 71

Last Updated: 09/26/2026